RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-2.71%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.86B
AUM Growth
+$1.86B
(-20%)
Cap. Flow
-$292M
Cap. Flow
% of AUM
-15.67%
Top 10 Holdings %
Top 10 Hldgs %
79.17%
Holding
33
New
4
Increased
4
Reduced
3
Closed
8
Top Buys
1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$64M |
2 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$36.2M |
3 |
Stoke Therapeutics
STOK
|
$32.7M |
4 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$27.2M |
5 |
X4 Pharmaceuticals
XFOR
|
$12.9M |
Top Sells
1 |
InflaRx
IFRX
|
$106M |
2 |
BioCryst Pharmaceuticals
BCRX
|
$70.5M |
3 |
SAGE
Sage Therapeutics
SAGE
|
$61.1M |
4 |
Axsome Therapeutics
AXSM
|
$50.3M |
5 |
KalVista Pharmaceuticals
KALV
|
$41.2M |
Sector Composition
1 | Healthcare | 97.92% |